BH
Benjamin Hohl
DELAYED 1 MONTH
CHIEF FINANCIAL OFFICER
Enliven Therapeutics, Inc.
Filings
1
Companies
1
Latest
Mar 6, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
57
Enliven Therapeutics, Inc.
Benjamin Hohl
CHIEF FINANCIAL OFFICER
Sale
$295.8K
10,000 sh
Mar 10 10:15 PM
Mar 6, 2026